Molecular tests are far superior to rapid antigen tests—and now you can get them for home use. Amanda Blum is a freelancer who writes about smart home technology, gardening, and food preservation.

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...

Molecular tests to detect Zika virus, which enable identification of the pathogen's genetic material in body fluids, such as blood, urine, semen and saliva during the acute phase of infection, have ...

In the article that accompanies this editorial, Smith et al 9 examine the association between availability of molecular testing before treatment decisions and outcomes such as time to next treatment ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

There are currently two options for at-home flu testing. Here's what you need to know. (Photo illustration: Yahoo News; photos: Getty Images) Many Americans have become accustomed to swabbing their ...

The fraction, volume and frequency of the patient sample collection; DNA extraction and purification procedures, which greatly influence the performance of the downstream molecular tests. It is worth ...

CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...

SkylineDx said it published new peer-reviewed data where its Merlin CP-GEP Test outperforms the competition and current standards of care for identifying melanoma risk using molecular testing. In ...

NCCN's newly updated NSCLC guidelines add sevabertinib as a treatment option and datopotamab deruxtecan-dlink a potential preferred option.